0.24 (-1.02%)
As of Dec 22, 2021
Source:
Ayala Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm Technology antigen delivery products based on a platform technology that utilizes live attenuated Listeria monocytogenes, or Lm, bioengineered to secrete antigen/adjuvant fusion proteins.
| Country | United States |
| Headquarters | monmouth junction, new jersey |
| Phone Number | 732 545 1590 |
| Industry | manufacturing |
| CEO | Kenneth Berlin |
| Website | ayalapharma.com |